YL

Yanke Liang

DI Dana-Farber Cancer Institute: 19 patents #27 of 1,343Top 3%
CT C4 Therapeutics: 14 patents #2 of 35Top 6%
The General Hospital: 8 patents #184 of 3,021Top 7%
TI The Broad Institute: 6 patents #77 of 760Top 15%
Hoffmann-La Roche: 3 patents #991 of 3,238Top 35%
Harvard University: 1 patents #1,740 of 3,600Top 50%
📍 Belmont, MA: #40 of 1,163 inventorsTop 4%
🗺 Massachusetts: #2,253 of 88,656 inventorsTop 3%
Overall (All Time): #91,516 of 4,157,543Top 3%
36
Patents All Time

Issued Patents All Time

Showing 1–25 of 36 patents

Patent #TitleCo-InventorsDate
12421220 Bicyclic-substituted glutarimide cereblon binders Christopher G. Nasveschuk, Kiel Lazarski, Alexander Hird, Ning Yin, Andrew C. Good +3 more 2025-09-23
12398145 Bicyclic urea kinase inhibitors and uses thereof Nathanael S. Gray, Hwan Geun Choi, Thomas Sundberg, Alykhan Shamji, Ramnik Xavier +2 more 2025-08-26
12371442 Isoindolinone and indazole compounds for the degradation of EGFR Christopher G. Nasveschuk, Martin Duplessis, Jae Young Ahn, Alexander Hird, Ryan E. Michael +5 more 2025-07-29
12209091 Isoindolinone derivatives as selective allosteric inhibitors of Egfr mutant cancers Martin Duplessis, Annick Goergler, Georg Jaeschke, Buelent Kocer, Bernd Kuhn +6 more 2025-01-28
12209076 Imidazolyl kinase inhibitors and uses thereof Nathanael S. Gray, Hwan Geun Choi 2025-01-28
12180225 N/O-linked degrons and degronimers for protein degradation Andrew J. Phillips, Christopher G. Nasveschuk, James A. Henderson, Minsheng He, Martin Duplessis +1 more 2024-12-31
12168663 Inhibitors of cyclin-dependent kinase 7 (CDK7) Nathanael S. Gray, Tinghu Zhang, Nicholas Paul Kwiatkowski 2024-12-17
12121521 Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis Marc Wein, Henry M. Kronenberg, Thomas Sundberg, Ramnik Xavier, Nathanael S. Gray +2 more 2024-10-22
12076405 Heterocyclic degronimers for target protein degradation Andrew J. Phillips, Christopher G. Nasveschuk, James A. Henderson, Mark Fitzgerald, Minsheng He +1 more 2024-09-03
12048747 Substituted piperidine Degronimers for Target Protein degradation Andrew J. Phillips, Christopher G. Nasveschuk, James A. Henderson, Chi-Li Chen, Martin Duplessis +2 more 2024-07-30
12048748 Spirocyclic degronimers for target protein degradation Andrew J. Phillips, Christopher G. Nasveschuk, James A. Henderson, Kiel Lazarski, Ryan E. Michael 2024-07-30
11992531 C3-carbon linked glutarimide degronimers for target protein degradation Andrew J. Phillips, Christopher G. Nasveschuk, James A. Henderson, Minsheng He, Kiel Lazarski +2 more 2024-05-28
11878019 Uses of pyrimidopyrimidinones as SIK inhibitors David E. Fisher, Nisma Mujahid, Ryo Murakami, Nathanael S. Gray, Hwan Geun Choi 2024-01-23
11827636 Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of use Nathanael S. Gray, Tinghu Zhang, Calla M. Olson, Nicholas Paul Kwiatkowski 2023-11-28
11725011 Bicyclic urea kinase inhibitors and uses thereof Nathanael S. Gray, Hwan Geun Choi, Thomas Sundberg, Alykhan Shamji, Ramnik Xavier +2 more 2023-08-15
11708354 2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds Martin Duplessis, Georg Jaeschke, Bernd Kuhn, Kiel Lazarski, Yvonne Alice Nagel +3 more 2023-07-25
11673902 Isoindolinone and indazole compounds for the degradation of EGFR Christopher G. Nasveschuk, Martin Duplessis, Jae Young Ahn, Alexander Hird, Ryan E. Michael +5 more 2023-06-13
11459335 N/O-linked Degrons and Degronimers for protein degradation Andrew J. Phillips, Christopher G. Nasveschuk, James A. Henderson, Minsheng He, Martin Duplessis +1 more 2022-10-04
11285158 Uses of pyrimidopyrimidinones as SIK inhibitors David E. Fisher, Nisma Mujahid, Ryo Murakami, Nathanael S. Gray, Hwan Geun Choi 2022-03-29
11247991 Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of use Nathanael S. Gray, Tinghu Zhang, Calla M. Olson, Nicholas Paul Kwiatkowski 2022-02-15
11241435 Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis Marc Wein, Henry M. Kronenberg, Thomas Sundberg, Ramnik Xavier, Nathanael S. Gray +2 more 2022-02-08
11185592 Spirocyclic degronimers for target protein degradation Andrew J. Phillips, Christopher G. Nasveschuk, James A. Henderson, Kiel Lazarski, Ryan E. Michael 2021-11-30
10975058 Imidazolyl kinase inhibitors and uses thereof Nathanael S. Gray, Hwan Geun Choi 2021-04-13
10954242 Bicyclic urea kinase inhibitors and uses thereof Nathanael S. Gray, Hwan Geun Choi, Thomas Sundberg, Alykhan Shamji, Ramnik Xavier +2 more 2021-03-23
10905768 Heterocyclic degronimers for target protein degradation Andrew J. Phillips, Chris G. Nasveschuk, James A. Henderson, Mark Fitzgerald, Minsheng He +1 more 2021-02-02